Picard Medical

PMI

Market cap $7.35M

–First public scientific presentation provides the biomedical engineering community with its first detailed view of the next-generation total artificial heart platform– –First public scientific presentation provides the biomedical engineering community with its first detailed view of the next-generation total artificial heart platform–

-First scientific presentation of the Emperor Drive System architecture to the biomedical engineering community- TUCSON, Ariz., July 27, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) ("Picard" or the "Company"), parent company of SynCardia Systems LLC, maker of the world's first and only total artificial heart approved by the U.S. Food and Drug Administration (FDA) and Health Canada, today announced that Taha Hasekioglu, Director, Office of the COO & Emperor Program Lead, will present new engineering insights into the Company's next-generation Emperor Total Artificial Heart (Emperor TAH) system during the 48th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC 2026), taking place July 26–30, 2026, in Toronto, Canada.

-Company continues advancing long-term growth strategy under accepted compliance plan- -Company continues advancing long-term growth strategy under accepted compliance plan-

-Reverse stock split to support continued compliance with NYSE American continued listing standards- TUCSON, Ariz., July 21, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (the "Company" or "Picard Medical"), parent company of SynCardia Systems LLC, maker of the world's first and only total artificial heart approved by both the U.S. Food and Drug Administration ("FDA") and Health Canada, today announced that its Board of Directors has approved the implementation of a 1-for-50 reverse stock split of the Company's issued and outstanding common stock (the “Reverse Stock Split”).

Picard Medical, Inc. (PMI) Shareholder/Analyst Call Prepared Remarks Transcript

Peer-reviewed journal's News section highlights the Company's continued progress toward a fully implantable total artificial heart Peer-reviewed journal's News section highlights the Company's continued progress toward a fully implantable total artificial heart

Presentation Highlights Business Progress, Product Development Milestones, and Matters for Stockholder Consideration Presentation Highlights Business Progress, Product Development Milestones, and Matters for Stockholder Consideration

- Presentation Highlights Business Progress, Product Development Milestones, and Matters for Stockholder Consideration- - Presentation Highlights Business Progress, Product Development Milestones, and Matters for Stockholder Consideration-

NEW YORK, June 25, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Picard Medical, Inc. (NYSE American: PMI) breached their fiduciary duties to shareholders.

Vancouver, British Columbia--(Newsfile Corp. - June 25, 2026) - Perseverance Metals Inc. (TSXV: PMI) ("Perseverance", "PMI" or the "Company") is pleased to announce that its Board of Directors has appointed Isabelle Cadieux as an Independent Director, effective immediately. Ms. Cadieux, a Professional Geologist in the province of Québec, has over 35 years of experience in mineral exploration and the mining sector in both technical and financial roles, including serving for over 20 years as the Managing Director, Investment at SIDEX - a Québec institutional fund focused on exploration-stage companies in the province.